通过调解建模,统一分析肝炎自然史的半竞争性风险分析
Jih-Chang Yu1, Yen-Tsung Huang1
1Institute of Statistical Science, Academia Sinica, Taipei, Taiwan.
Statistics in medicine
|August 1, 2023
概括
这项研究引入了一个调解框架来分析肝炎的半竞争性风险,揭示了B型肝炎和C型肝炎如何通过促进肝硬化增加肝癌风险. 这种方法统一了分析疾病进展的各种统计模型.
科学领域:
- 生物统计学 生物统计学
- 流行病学 流行病学
- 肝病学 肝病学是一种肝病学.
背景情况:
- B型肝炎和C型肝炎的自然史涉及肝硬化和肝癌等关键里程碑.
- 半竞争性风险,其中一个事件 (肝硬化) 可以被另一个事件 (癌症) 审查,复杂分析.
- 现有的模型,如,脆弱性和多状态模型,解决了半竞争性风险,但缺乏统一的框架.
研究的目的:
- 引入一种新的调解框架,用于分析在肝炎方面存在的半竞争性风险.
- 定义和推导暴露对肝癌发病率的间接 (中介) 和直接影响.
- 在一个单一的分析结构中统一现有的半竞争性风险模型.
主要方法:
- 将半竞争性风险作为一个调解问题,以肝硬化为调解者和肝癌作为结果.
- 导出估计值作为条件概率在,脆弱性和多状态模型下.
- 提出非参数最大概率和基于U统计的估计器,使用非对称分析.
主要成果:
- 调解建模为分析半竞争性风险提供了统一的方法.
- 形模型提供效率,但风险偏差来自错误规范;脆弱模型是强大的,但效率较低.
- 多州模型实现了效率和稳定性之间的平衡.
- B型肝炎和C型肝炎增加了肝癌的发病率,主要是通过提高肝硬化率.
结论:
- 调解建模为了解具有半竞争风险的复杂疾病进展提供了一个多功能和统一的框架.
- 提出的方法为分析肝炎对肝癌发展的影响提供了强大的工具.
- 了解肝硬化中介途径对于有效的肝炎管理和预防策略至关重要.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
61
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
61
01:18Models of Health Promotion and Illness Prevention II
1.6K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
The agent-host-environment model states that disease results...
1.6K
01:12Relative Risk
219
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
219
01:12Hazard Ratio
159
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
159